Immediate Impact

2 from Science/Nature 70 standout
Sub-graph 1 of 23

Citing Papers

Inflammatory response of nanoparticles: Mechanisms, consequences, and strategies for mitigation
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
6 intermediate papers

Works of Jun Kawashima being referenced

Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure
2018
Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis
2013
and 4 more

Author Peers

Author Last Decade Papers Cites
Jun Kawashima 514 400 11 347 63 635
Tomasz Sacha 379 436 36 162 90 682
Prashanth Gopalakrishna 440 392 1 272 28 592
Emmanuelle Verger 458 428 8 291 34 647
Daniele Cattaneo 365 341 29 192 64 574
Barbara Scappini 238 388 185 42 566
Giuseppina Fugazza 226 327 13 225 36 589
Soji Morishita 420 350 10 337 49 656
Tiejun Qin 310 454 10 227 83 571
Manuel Pérez‐Encinas 263 317 18 224 47 515
Nicolas Chatain 264 247 15 359 45 710

All Works

Loading papers...

Rankless by CCL
2026